Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Quintiles Transnational (NasdaqNM:QTRN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
4709 Creekstone Drive, Suite 200
Durham, NC 27703
Phone: (919) 998-2000
Fax: (919) 941-9113
Email: invest@quintiles.com
Employees (last reported count): 18,219
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 47%
·Over the last 6 months:
 · one insider buy; 1,000  shares
 · 6 insider sells; 397.0K shares
  (0.7% of insider shares)
·Institutional: 77% (144% of float)
(549 institutions)
·Net Inst. Buying: 9.22M shares (+9.15%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Quintiles Transnational Corp. is engaged in providing a full range of integrated product development and commercial development solutions to the pharmaceutical, biotechnology and medical device industries. The Company provides market research solutions and strategic analyses to support healthcare decisions and healthcare policy consulting to governments and other organizations worldwide. The Company provides a broad range of contract services to help its clients reduce the length of time from the beginning of development to peak sales of a new drug or medical device. Its product development services include a full range of services focused on helping its clients through the development and regulatory approval of a new drug or medical device. Its commercial development services focus on helping its clients achieve commercial success for a new product or medical device. In addition, Quintiles offers healthcare policy research and management consulting.
More from Market Guide: Expanded Business Description

Financial Summary
Quintiles Transnational is engaged in the provision of full-service contract research, sales and marketing and healthcare policy consulting services to the global pharmaceutical, biotechnology and medical device industries. For the six months ended 6/30/01, revenues fell 3% to $808.8 million. Net income from continuing operations totalled $17.5 million vs. a loss of $45.4 million. Revenues reflect lower contract service offerings. Earnings reflect reduced restructuring charges.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Dennis Gillings, Ph.D, 56
Chairman
$1.2M$481K
Pamela Kirby, Ph.D., 47
CEO
--  --  
Santo Costa, 55
Vice Chairman
856K65K
James Bierman, 48
CFO
266K--  
Jim Kever, 48
Director and CEO of ENVOY
388K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:QTRNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 23-Oct-2000
$12.50 
Recent Price$17.51 
52-Week High
on 29-June-2001
$26.05 
Beta0.42 
Daily Volume (3-month avg)1.78M
Daily Volume (10-day avg)911.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+25.6%
52-Week Change
relative to S&P500
+68.5%
Share-Related Items
Market Capitalization$2.09B
Shares Outstanding119.6M
Float63.4M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 2-Dec-1997
Per-Share Data
Book Value (mrq)$11.80 
Earnings (ttm)$0.24 
Earnings (mrq)$0.08 
Sales (ttm)$13.73 
Cash (mrq)$3.67 
Valuation Ratios
Price/Book (mrq)1.48 
Price/Earnings (ttm)72.66 
Price/Sales (ttm)1.27 
Income Statements
Sales (ttm)$1.63B
EBITDA (ttm)$111.8M
Income available to common (ttm)$28.7M
Profitability
Profit Margin (ttm)1.8%
Operating Margin (ttm)1.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)1.41%
Return on Equity (ttm)1.98%
Financial Strength
Current Ratio (mrq)1.81 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$439.7M
Short Interest
As of 8-Aug-2001
Shares Short2.75M
Percent of Float4.3%
Shares Short
(Prior Month)
4.09M
Short Ratio1.35 
Daily Volume2.04M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.